套住了 止损查看全文
牛唐2020-06-19 14:01
生物医药领域成为疫情期间IPO的亮点,在过去两个月里,包括$Lyra Therapeutics(LYRA)$ 在内,有4家上市公司都属于生物医药的范畴,包括$ORIC制药(ORIC)$ ,$Keros(KROS)$ ,以及Zentalis Pharmaceuticals。这些生物医药公司不仅顺利IPO,而且平均回报率达82%查看全文
$Lyra Therapeutics(LYRA)$ 内部交易: 2021-06-17,Director,MERRIFIELD C ANN ,买入,3500普通股, $8.97
$Lyra Therapeutics(LYRA)$ 8-K Current report, item 8.01 Accession Number: 0001193125-21-188987 Act: 34 Size: 20 KB 网页链接
$Lyra Therapeutics(LYRA)$ 8-K Current report, item 1.01 Accession Number: 0001193125-21-182884 Act: 34 Size: 22 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-21-021189 Size: 5 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-21-021191 Size: 5 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-21-021184 Size: 5 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-21-021185 Size: 5 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-21-021186 Size: 5 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-21-021187 Size: 5 KB 网页链接
$Lyra Therapeutics(LYRA)$ 8-K Current report, item 5.07 Accession Number: 0001564590-21-030615 Act: 34 Size: 37 KB 网页链接